At ANGLE we are committed to adopting best practise with respect to our impact on society and the environment
We believe that investing in culture and community and in making a positive impact on the environment which will help the Group meet business, financial and commercial objectives.
These efforts are investments toward a sustainable future. Our commitments go beyond the requirements of the regulatory environments in which we operate and include:
- Estabilished sustainability and ESG Reporting Team
- Using World Wide Generation (WWG) we measure, track and report relevant social economic and environmental impacts, benchmarked against key policies, standards and framework in support of UN Sustainable Development Goals
- ISO 13485:2016 quality system certification
Our offices use 100% renewable energy, LED lights and other energy-efficient, low energy systems
Environmental
We view the protection of the environment as a core priority despite our small environmental footprint and low relative climate risk
- Parsortix technology uses pressure to harvest cells rather than a chemical approach reducing/negating the requirement for antibody reagents and other chemicals
- We restrict business travel to necessity, promote use of video conferencing, and encourage home / flexible working, cycle to work and carpool schemes
- Our landlord’s waste management services seek to divert landfill and recycle as much as possible, and we utilise several other specialist recycling services and systems
Sustainability reporting
In 2021, ANGLE further responded to increasing investor demand for transparency and higher standards of sustainability reporting by engaging with World Wide Generation (WWG), the provider of a leading digital reporting tool for small and mediums sized companies
With a view to enabling the collection of reliable and consistent data on ANGLE’s performance, an ANGLE team has been assembled with contributors from across functions (e.g. finance, human resources, R&D, manufacturing, clinical laboratories) and across each of ANGLE’s geographic locations.
The team is now in the process of identifying the relevant standards and frameworks and building its initial database of key metrics and data. Once complete, the Company will be in a position to set targets for future performance and develop the required internal policies and procedures to capture the necessary data and move towards meeting those targets.
ANGLE’s sustainability reporting will evolve as this work progresses.
Human capital
Finding and keeping the best people
We offer competitive and comprehensive salary packages reviewed and benchmarked annually with benefits packages and key roles regularly benchmarked to determine our level of competitiveness.
ANGLE offers flexible working to accommodate individuals’ needs and commitments outside the workplace. 10% of our staff are employed on a part-time and a significant proportion of staff are able to balance working with caring for children.
The Group works with Universities to support science and operate an effective placement programe in both the UK and North America. In the UK we offer placements to up to six undergraduate students each year.
Training and development
We place a high priority on training and development throughout our organisation from the start of a career at ANGLE and seek to promote staff internally, maximising the potential for career progression and development.
Diversity and equal opportunity
We recognise the diversity and potential different people can bring to their work and are committed to equal opportunities in the provision of services and employment.
ANGLE avoids discrimination or harassment of any kind and specifically on the grounds of race, colour, nationally, ethnic, or national origin, relation, gender, marital status, sexual orientation, medical condition including progressive illness, age and disability.
Product quality
We are committed to providing quality in-vitro diagnostic devices and accessories for the capture, harvest and analysis of cells present in blood, based on their size and deformablity. We fulfil all market and regulatory requirements to meet the needs of the customer and for the benefit of the patient.
The quality of medical devices as a minimum will conform to the In Vitro Diagnostic Directive 98/79/EC (transitioning to In Vitro Diagnostic Regulation EU 2017/746). FDA GMP 21 CFR 820 and other requirements as applicable to the countries in which the device or services is intended.
Quality Management Systems fall within the scope of ISO 13485:2016 and all quality procedures are maintained to this standard.
Health and safety a shared responsibility
We are committed to ensuring high standards of health and safety for employees, visitors and the general public.
ANGLE complies with all applicable laws and regulations. We use expert independent advisors to audit our operations to ensure compliance is on-going and effective.
Each of our locations has a joint health and safety committee made up of both employees and management. This activity is strengthened by specialist health and safety advisors in both the UK and US.
Zero Tolerance of Workplace Harassment
We are committed to the prevention of workplace violence and harassment and to protecting the health and safety of our employees in the workplace.
All ANGLE employees are encouraged to work together to support a safe, healthy and respectful workplace.
Community, charity and outreach
We work with a number of charitable organisations such as Cancer Research UK and have donated products and funded medical research in pursuit of our mission.
Governance
The Board is committed to high standards of corporate governance and adheres to the Quotes Companies Alliance (QCA) Corporate Governance Code for small and mid-size quoted companies (the QCA Code).
As we grow, we are striving to ensure that our values are upheld and a collaborative, supportive and inclusive culture continues to develop. Our Management Charter sets out the expectations of all employees in managerial roles.
Lessons for the future
Our work-from-home strategy, implemented as a result of the COVID-19 pandemic has been maintained and enhanced, supporting employees with necessary resources, utilising digital technologies to maintain connections, communication and flexibility in working hours.
Employee wellbeing and mental health remain a priority. Employee Assistance Programmes are in place to offer confidential support, counselling and advice.
Social (community)
ANGLE understands that long-term growth and business performance depends on the talent, skills and passions of our employees.
We aim to create a work environment that appeals to, empowers and involves all employees at every level of the organisation.
We foster links to and support future talent through graduate schemes, Erasmus exchange programmes and apprenticeship opportunities.
Human capital
Finding and keeping the best people
Training and development
Diversity and equal opportunity
Product quality
Health and safety a shared responsibility
Community, charity and outreach
Human capital
Finding and keeping the best people
We offer competitive and comprehensive salary packages reviewed and benchmarked annually with benefits packages and key roles regularly benchmarked to determine our level of competitiveness.
ANGLE offers flexible working to accommodate individuals’ needs and commitments outside the workplace. 10% of our staff are employed on a part-time and a significant proportion of staff are able to balance working with caring for children.
The Group works with Universities to support science and operate an effective placement programe in both the UK and North America. In the UK we offer placements to up to six undergraduate students each year.
Training and development
We place a high priority on training and development throughout our organisation from the start of a career at ANGLE and seek to promote staff internally, maximising the potential for career progression and development.
Diversity and equal opportunity
We recognise the diversity and potential different people can bring to their work and are committed to equal opportunities in the provision of services and employment.
ANGLE avoids discrimination or harassment of any kind and specifically on the grounds of race, colour, nationally, ethnic, or national origin, relation, gender, marital status, sexual orientation, medical condition including progressive illness, age and disability.
Product quality
We are committed to providing quality in-vitro diagnostic devices and accessories for the capture, harvest and analysis of cells present in blood, based on their size and deformablity. We fulfil all market and regulatory requirements to meet the needs of the customer and for the benefit of the patient.
The quality of medical devices as a minimum will conform to the In Vitro Diagnostic Directive 98/79/EC (transitioning to In Vitro Diagnostic Regulation EU 2017/746). FDA GMP 21 CFR 820 and other requirements as applicable to the countries in which the device or services is intended.
Quality Management Systems fall within the scope of ISO 13485:2016 and all quality procedures are maintained to this standard.
Health and safety a shared responsibility
We are committed to ensuring high standards of health and safety for employees, visitors and the general public.
ANGLE complies with all applicable laws and regulations. We use expert independent advisors to audit our operations to ensure compliance is on-going and effective.
Each of our locations has a joint health and safety committee made up of both employees and management. This activity is strengthened by specialist health and safety advisors in both the UK and US.
Zero Tolerance of Workplace Harassment
We are committed to the prevention of workplace violence and harassment and to protecting the health and safety of our employees in the workplace.
All ANGLE employees are encouraged to work together to support a safe, healthy and respectful workplace.
Community, charity and outreach
We work with a number of charitable organisations such as Cancer Research UK and have donated products and funded medical research in pursuit of our mission.